非痴呆性衰老的神经病理学:临床前阿尔茨海默病的推测性证据。

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

作者信息

Price Joseph L, McKeel Daniel W, Buckles Virginia D, Roe Catherine M, Xiong Chengjie, Grundman Michael, Hansen Lawrence A, Petersen Ronald C, Parisi Joseph E, Dickson Dennis W, Smith Charles D, Davis Daron G, Schmitt Frederick A, Markesbery William R, Kaye Jeffrey, Kurlan Roger, Hulette Christine, Kurland Brenda F, Higdon Roger, Kukull Walter, Morris John C

机构信息

Department of Anatomy and Neurobiology, Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.

出版信息

Neurobiol Aging. 2009 Jul;30(7):1026-36. doi: 10.1016/j.neurobiolaging.2009.04.002. Epub 2009 Apr 18.

Abstract

OBJECTIVE

To determine the frequency and possible cognitive effect of histological Alzheimer's disease (AD) in autopsied older nondemented individuals.

DESIGN

Senile plaques (SPs) and neurofibrillary tangles (NFTs) were assessed quantitatively in 97 cases from 7 Alzheimer's Disease Centers (ADCs). Neuropathological diagnoses of AD (npAD) were also made with four sets of criteria. Adjusted linear mixed models tested differences between participants with and without npAD on the quantitative neuropathology measures and psychometric test scores prior to death. Spearman rank-order correlations between AD lesions and psychometric scores at last assessment were calculated for cases with pathology in particular regions.

SETTING

Washington University Alzheimer's Disease Research Center.

PARTICIPANTS

Ninety-seven nondemented participants who were age 60 years or older at death (mean=84 years).

RESULTS

About 40% of nondemented individuals met at least some level of criteria for npAD; when strict criteria were used, about 20% of cases had npAD. Substantial overlap of Braak neurofibrillary stages occurred between npAD and no-npAD cases. Although there was no measurable cognitive impairment prior to death for either the no-npAD or npAD groups, cognitive function in nondemented aging appears to be degraded by the presence of NFTs and SPs.

CONCLUSIONS

Neuropathological processes related to AD in persons without dementia appear to be associated with subtle cognitive dysfunction and may represent a preclinical stage of the illness. By age 80-85 years, many nondemented older adults have substantial AD pathology.

摘要

目的

确定老年非痴呆个体尸检中组织学阿尔茨海默病(AD)的频率及其可能的认知影响。

设计

对来自7个阿尔茨海默病中心(ADC)的97例病例进行了老年斑(SPs)和神经原纤维缠结(NFTs)的定量评估。还采用四套标准对AD进行了神经病理学诊断(npAD)。调整后的线性混合模型测试了在定量神经病理学测量和死亡前心理测量测试分数方面,有和没有npAD的参与者之间的差异。对特定区域有病理学改变的病例,计算了末次评估时AD病变与心理测量分数之间的Spearman等级相关性。

地点

华盛顿大学阿尔茨海默病研究中心。

参与者

97名非痴呆参与者,死亡时年龄在60岁及以上(平均84岁)。

结果

约40%的非痴呆个体至少符合一定程度的npAD标准;采用严格标准时,约20%的病例患有npAD。npAD和非npAD病例之间Braak神经原纤维阶段存在大量重叠。虽然非npAD组和npAD组在死亡前均未出现可测量的认知障碍,但非痴呆老年人的认知功能似乎因NFTs和SPs的存在而下降。

结论

无痴呆人群中与AD相关的神经病理学过程似乎与轻微认知功能障碍有关,可能代表疾病的临床前期阶段。到80 - 85岁时,许多非痴呆老年人有大量AD病理学改变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索